Delivery Order SPE2DX15D3504-SPE2DX25F00A5

Award Date 10/15/24
Potential Completion Date 10/16/24
Potential Value $4.9K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of Primaquine 26.3 mg tablets in quantities of 100 per bottle. The $1,070.42 fixed-price contract was awarded on June 27, 2024 by the Defense Logistics Agency (DLA), a defense agency, with an ultimate completion date of June 28, 2024. The contract is not set aside for any particular business type. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of Primaquine 26.3 mg tablets. The $8,855.74 Firm Fixed Price delivery order has an ultimate completion date of April 18, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA) healthcare...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,599.35, is for the delivery of Primaquine 26.3 mg tablets over a period ending on March 28, 2025. This is a firm-fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, to Amerisourcebergen Drug Corp's Corporate Office Division. The $9,664.20 firm fixed-price delivery order is for the supply of 4,558,735,941 units of the pharmaceutical product Primaquine 26.3 mg Tablet in 100 tablet containers. The award is not associated with a set-aside program and is part of Amerisourcebergen's larger $999,999,999.00 Indefinite...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Primaquine 26.3 mg tablets, a pharmaceutical product, with a ceiling value of $1,122.00 and a completion date of July 7, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The award, valued at $1,648.66, is for the delivery of 4564360935 - Primaquine 26.3 mg tablets in quantities of 100 per bottle. The contract has an ultimate completion date of April 23, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,662.40 firm fixed-price delivery order is for Primaquine 26.3 mg tablets and does not have a set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The contract, valued at $5,881.92, is a delivery order for 4,565,390,595 Primaquine 26.3 mg tablets. The contract does not have a set-aside designation and has a period of performance through August 9, 2024. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous federal contracts to supply a wide...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $77,462.63 Firm Fixed Price delivery order is for the supply of Primaquine 26.3mg tablets, with an ultimate completion date of October 9, 2015. The contract is not designated as a set-aside and represents a standard open competition award. Amerisourcebergen holds a significant $999,999,999...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The contract provides for the delivery of Primaquine 26.3mg tablets, a pharmaceutical product, to support military healthcare programs. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, as the prime...
  • SPE2DX15D3504
    Indefinite Delivery Contract
  • SPE2DX15D3504-SPE2DX25F00A5
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division involves the delivery of Primaquine 26.3 mg tablets (100s) to the U.S. government. The contract, valued at $4,927.49, was awarded on October 15, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, a major customer for Amerisourcebergen. The contract has a firm fixed price and an ultimate completion date of October 16, 2024. This award is part of Amerisourcebergen's broader support of federal healthcare programs, including military treatment facilities and veterans' hospitals, through its extensive pharmaceutical and medical supply distribution capabilities. The company holds several Indefinite Delivery Contracts (IDCs) with federal agencies such as the DLA and the Department of Justice Federal Bureau of Investigation, valued up to $999,999,999 and $750,000 respectively, to efficiently provide a wide range of critical medical commodities. This contract does not have a set-aside designation.

Generated 1/14/25, 9:23 AM